Mary Luz Mojica-Pisciotti

Mary Luz Mojica-Pisciotti

Auto-generated profile, based on publicly available information

Mary Luz Mojica-Pisciotti

International Clinical Research Center, St. Anne’s University Hospital, Brno, Czech Republic

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2014 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
PDF file
MPM. L. Mojica Pisciotti
M. L. Mojica Pisciotti
ELE. Lima
E. Lima
MMM. Vasquez Mansilla
M. Vasquez Mansilla
VTV. E. Tognoli
V. E. Tognoli
HTH. E. Troiani
H. E. Troiani
RZR. D. Zysler
R. D. Zysler

1 May 2016 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
ASAdny H. Silva
Adny H. Silva
ELEnio Lima
Enio Lima
MMMarcelo Vasquez Mansilla
Marcelo Vasquez Mansilla
RZRoberto D. Zysler
Roberto D. Zysler
HTHoracio Troiani
Horacio Troiani
TCTania Creczynski-Pasa
Tania Creczynski-Pasa

31 July 2019 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
AMAna Carolina Moreno Maldonado
Ana Carolina Moreno Maldonado
EWElin L. Winkler
Elin L. Winkler
MRMariana Raineri
Mariana Raineri
ACAlfonso Toro Córdova
Alfonso Toro Córdova
LRLuis M. Rodríguez
Luis M. Rodríguez
ELEnio Lima
Enio Lima

23 December 2014 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
ELEnio Lima
Enio Lima
EBEmilio De Biasi
Emilio De Biasi
RZRoberto D. Zysler
Roberto D. Zysler
MMMarcelo Vasquez Mansilla
Marcelo Vasquez Mansilla
MMMary L. Mojica-Pisciotti
Mary L. Mojica-Pisciotti
Gerardo F. GoyaGerardo F. Goya
Gerardo F. Goya

27 October 2023 in European Journal of Neurology
Verified
Journal Article
Open access
VKVladimír Kincl
Vladimír Kincl
RPRoman Panovský
Roman Panovský
MBMartina Bočková
Martina Bočková
IRIvan Rektor
Ivan Rektor
MMMary Luz Mojica‐Pisciotti
Mary Luz Mojica‐Pisciotti
JMJan Machal
Jan Machal
Background: The known impairments of the cardiovascular system in Parkinson´s disease (PD) are caused by autonomic dysfunction and manifested mainly in postural hypotension, chronotropic insufficiency, and reduced heart rate variability. Other dysfunctions, mainly stress response, arrhythmia occurrence, and heart morphology changes, are still the subject of research.Objectives: To assess the heart rate and blood pressure reaction during exercise, advanced measurements of heart volumes and mass using cardiac magnetic resonance (CMR), and occurrence of arrhythmias in PD patients.Methods: Thirty PD patients (19 men, mean age 57.5 years) without known cardiac comorbidities underwent bicycle ergometry, electrocardiogram Holter monitoring and CMR. Exercise and CMR parameters were compared with controls (24 subjects for ergometry, 20 for CMR).Results: PD patients had lower baseline systolic blood pressure (SBP) (117.8 vs. 128.3 mmHg, p < 0.01), peak SBP (155.8 vs. 170.8 mmHg, p < 0.05), and lower heart rate increase (49.7 vs. 64.3 beats per minute, p < 0.01). PD patients had higher indexed left and right ventricular end‐diastolic volumes (68.5 vs. 57.3, p = 0.003 and 73.5 vs. 61.0 mL/m2, respectively) and also indexed left and right ventricular end‐systolic volumes (44.1 vs. 39.0, p = 0.013 and 29.0 vs. 22.0 mL/m2, p = 0.013, respectively). A high prevalence of atrial fibrillation (8 subjects, 26.7%) was found.Conclusions: This novel study combining functional and structural approaches showed that PD is linked with weaker blood pressure and heart rate reaction during exercise, increased myocardial mass and heart volumes compared to controls, and a high prevalence of atrial fibrillation.

1 January 2013 in Journal of Biomedical Nanotechnology
Verified
Journal Article
Closed access
RZR. D. Zysler
R. D. Zysler
JLJr E. Lima
Jr E. Lima
MMM. Vasquez Mansilla
M. Vasquez Mansilla
HTH. E. Troiani
H. E. Troiani
MPM. L. Mojica Pisciotti
M. L. Mojica Pisciotti
LCL. Colombo
L. Colombo
We propose a new method for determining the quantity of superparamagnetic iron oxide nanoparticles (Fe3O4, SPIONs) embedded in animal tissue using magnetization measurements. With this method, the smallest detectable quantity of magnetite nanoparticles in a tissue sample is ∼1 μg. We showed that this method has proved being efficient. In this study, we focused in determining the quantity of SPION confined in lung and liver tissue of mice injected with ∼13 nm magnetite superparamagnetic nanoparticles. Furthermore, the method allowed us to detect the magnetite nanoparticles present in animal tissues without letting the natural iron ions present in the tissue or blood interfere with the measurements.